Picture of boy being examining by doctor at a tuberculosis sanatorium

Understanding our future through Open Access research about our past...

Strathprints makes available scholarly Open Access content by researchers in the Centre for the Social History of Health & Healthcare (CSHHH), based within the School of Humanities, and considered Scotland's leading centre for the history of health and medicine.

Research at CSHHH explores the modern world since 1800 in locations as diverse as the UK, Asia, Africa, North America, and Europe. Areas of specialism include contraception and sexuality; family health and medical services; occupational health and medicine; disability; the history of psychiatry; conflict and warfare; and, drugs, pharmaceuticals and intoxicants.

Explore the Open Access research of the Centre for the Social History of Health and Healthcare. Or explore all of Strathclyde's Open Access research...

Image: Heart of England NHS Foundation Trust. Wellcome Collection - CC-BY.

Scottish Medicines Consortium Evaluation Programme December 2012

Bennie, Marion and Corcoran, Emma Dunlop and Dear, James W. and Hems, Sharon and McTaggart, S. and Newham, Rosemary and Norris, Vicky and Waugh, Craig (2012) Scottish Medicines Consortium Evaluation Programme December 2012. [Report] (Unpublished)

Full text not available in this repository. Request a copy from the Strathclyde author

Abstract

The Scottish Medicines Consortium (SMC) provides advice to the National Health Service (NHS) in Scotland about the comparative clinical and cost-effectiveness of all newly licensed medicines, new formulations of existing medicines and new indications for established products. SMC advice is conveyed to prescribers th rough the Detailed Advice Document (DAD), which is available on the SMC website and is disseminated to Area Drug and Therapeutics Committees (ADTCs) across Scotland. Since 2005, SMC has also provided a horizon scanning function and, through the Forward Look report, provides early intelligence to NHS Scotland on new medicines in development.